Isis Pharma (ISIS) Earns ISIS-DMPK-2.5Rx-Related Milestone Payment from Biogen
Tweet Send to a Friend
Isis Pharma (NASDAQ: ISIS) announced that it has earned a $2.8 million milestone payment from Biogen (Nasdaq: BIIB) related to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
